Prednisone Taper Schedule: Continue with 10 mg Daily, Then Taper by 2.5 mg Every 1-2 Weeks
After completing your 4-week initial taper (40→30→20→10 mg weekly), maintain 10 mg daily for at least 2-4 weeks, then reduce by 2.5 mg every 1-2 weeks until discontinuation, monitoring closely for disease recurrence.
Rationale for This Approach
The schedule you've described (40/30/20/10 mg weekly) represents a rapid initial taper commonly used in autoimmune conditions. However, the critical question is what happens after reaching 10 mg daily—and the evidence strongly supports a slower, more gradual approach from this point forward.
Why Slow Down at 10 mg?
From 20 mg down to 10 mg and below, the taper must become more conservative. Multiple guidelines across autoimmune hepatitis 1, 2, polymyalgia rheumatica 3, and inflammatory myopathies 4 consistently recommend:
- Reduction by 5 mg every 1-2 weeks until reaching 10 mg/day
- Then reduction by 2.5 mg every 1-2 weeks from 10 mg down to 5 mg
- Finally, reduction by 1 mg every 2-4 weeks below 5 mg until discontinuation
The autoimmune hepatitis guidelines specifically state: "from 20 mg daily onward, reduction should be done by 5 mg every week until 10 mg/day are achieved and even further reduction by 2.5 mg/week have been considered up to 5 mg daily" 1.
The One-Week Gap Issue
Your mention of a "1 week gap" is concerning. Never abruptly stop prednisone without tapering. The FDA label explicitly warns: "Avoid abrupt withdrawal of therapy" and "If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly" 5.
Abrupt discontinuation risks:
- Adrenal insufficiency (potentially life-threatening)
- Disease flare/rebound
- Withdrawal symptoms
Specific Tapering Algorithm After Your Initial 4 Weeks
Week 5 Onward:
- Maintain 10 mg daily for 2-4 weeks to ensure disease stability
- Week 7-8: Reduce to 7.5 mg daily (hold for 1-2 weeks)
- Week 9-10: Reduce to 5 mg daily (hold for 1-2 weeks)
- Week 11-12: Reduce to 2.5 mg daily (hold for 2 weeks)
- Week 13-14: Discontinue
Total duration: Approximately 12-14 weeks from start to finish
Alternative Slower Taper (Preferred for Higher-Risk Patients):
- From 10 mg: reduce by 2.5 mg every 2 weeks (not 1 week)
- From 5 mg: reduce by 1 mg every 2-4 weeks
- Total duration: 16-20 weeks
Critical Monitoring Points
Monitor for disease recurrence at each dose reduction, particularly:
- When dropping below 10 mg (most common flare point)
- When dropping below 5 mg (adrenal axis recovery zone)
- Within 2-4 weeks after complete discontinuation
The polymyalgia rheumatica guidelines emphasize: "Taper daily oral prednisone by 1 mg every 4 weeks (or by 1.25 mg decrements using schedules such as 10/7.5 mg alternate days, etc) until discontinuation given that remission is maintained" 3.
Evidence on Rapid vs. Slow Tapering
Recent high-quality evidence in acute autoimmune hepatitis demonstrates that slow corticosteroid tapering significantly reduces adverse outcomes. A 2025 multicenter study found that slow tapering (duration until prednisone <20 mg/day ≥3 weeks) resulted in 99% adverse outcome-free survival versus 71% with rapid tapering in acute icteric AIH (P<0.0001) 6. Slow tapering independently predicted fewer adverse events (OR 0.144; 95% CI 0.037-0.562; P=0.005).
Common Pitfalls to Avoid
- Tapering too quickly below 10 mg: This is where most relapses occur
- Abrupt discontinuation: Never stop suddenly, even at low doses
- Ignoring symptoms during taper: Any return of original symptoms warrants holding the taper or increasing the dose
- Not monitoring for adrenal insufficiency: Patients on >7.5 mg for >3 weeks are at risk 7
Practical Dosing Tips
- Take prednisone in the morning (before 9 AM) to minimize HPA axis suppression 5
- Take with food to reduce gastric irritation
- Use single daily dosing (not divided doses) unless specifically indicated 3
- Consider calcium (1000 mg/day) and vitamin D (800 IU/day) supplementation throughout treatment 2
When to Deviate from This Schedule
Increase back to previous dose if:
- Original symptoms return
- Laboratory markers worsen
- New concerning symptoms develop
Slow the taper further if:
- Patient has risk factors for relapse (young age, high disease activity at presentation)
- Previous failed taper attempts
- Comorbidities requiring caution (diabetes, osteoporosis, infections)
The evidence consistently shows that patience with steroid tapering improves long-term outcomes and reduces both disease flares and steroid-related complications 1, 3, 6.